Cellcolabs

Cellcolabs is a Swedish biotech company founded in 2021 with a GMP-certified production facility in Stockholm. It specializes in large-scale industrial manufacturing of high-quality mesenchymal stromal cells (MSCs) sourced from healthy donors, which possess anti-inflammatory, immunomodulatory, and regenerative properties. By providing these MSCs at scale and affordable prices for both research and clinical use, Cellcolabs is driving the acceleration of advanced cell therapies for the future of healthcare.